4D flow cardiac magnetic resonance postprocessing in congenital heart disease: SCMR FLIICR workgroup recommendations

Julio Garcia1, Julia Geiger2, Adam Christopher3

  • 1Department of Radiology, University of Calgary, Calgary, AB, Canada.

Insights

Cardiovascular magnetic resonance (CMR) with 4D flow imaging aids adults with congenital heart disease (CHD). This document outlines ideal software needs for 4D flow post-processing to enhance patient care.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Adult congenital heart disease (CHD) survival is high due to surgical advances.
  • Lifelong follow-up and non-invasive imaging are essential for CHD management.
  • Cardiovascular magnetic resonance (CMR) is a key non-invasive imaging modality for CHD, offering advantages over echocardiography.

Purpose of the Study:

  • To define the requirements for an "ideal" post-processing software for 4D flow cardiovascular magnetic resonance (CMR) in congenital heart disease (CHD) patients.
  • To guide the development of improved 4D flow post-processing and visualization tools for CHD.
  • To enhance the accuracy and efficiency of diagnostic and therapeutic patient care in CHD.

Main Methods:

  • The document addresses general requirements for 4D flow post-processing software.
  • Key technical aspects discussed include velocity encoding, offset and aliasing correction.
  • It also covers visualization, segmentation, reconstruction, and output data considerations.

Main Results:

  • Comprehensive post-processing of 4D flow data in CHD can be complex and demanding.
  • There is a need for specialized software to handle the intricacies of CHD hemodynamics.
  • Improved post-processing is crucial for maximizing the benefits of 4D flow CMR.

Conclusions:

  • The development of ideal 4D flow post-processing software is critical for advancing CHD care.
  • Enhanced software solutions will improve the accuracy and efficiency of CMR in CHD patients.
  • This initiative aims to support stakeholders in creating better tools for CHD management.